自组装的两性可以向VDAC1-hexokinase-II复合体,以诱导宫癌细胞的亡
Wanfeng Sun1, Angelina Angelova2, Xintong Han3
1School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai 200237, China.
Journal of medicinal chemistry
|September 12, 2025
概括
新型阴阳性类两类药物向VDAC1-Hexokinase-II复合体,诱导子宫癌细胞的亡. 这些自我组装的显示选择性癌细胞细胞毒性,提供了一个有前途的线粒体集中治疗策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 电压依赖离子通道1 (VDAC1) 是一种在癌症中过度表达的外部线粒体蛋白.
- 在调节亡过程中,VDAC1通过与抗亡蛋白相互作用并释放亡因子,起到至关重要的作用.
研究的目的:
- 为了研究针对宫癌线粒体中的VDAC1-Hexokinase-II复合体的新型多区块阴性两性蛋白.
- 评估这些的治疗潜力,以抑制宫癌的生长.
主要方法:
- 设计和合成带有修改的VDAC1片段LP1.1.的两性变体.
- 评估的自我组装成类似纳米纤维的结构.
- 在HeLa细胞中评估诱导的亡,包括线粒体膜潜力,细胞染色体C释放和酶激活.
- 对癌细胞和正常细胞进行选择性细胞毒性测试.
主要成果:
- 设计的可以自组装成类似纳米纤维的结构.
- 激发了HeLa细胞中的线粒体介导的亡,通过降低线粒体膜潜力,释放细胞染色体C,并激活隙.
- 一个被破坏的VDAC1-Hexokinase-II相互作用被建议.
- 对癌细胞具有选择性细胞毒性,对正常3T3细胞的影响最小.
结论:
- 针对VDAC1-Hexokinase-II复合体的两性是一种有前途的线粒体重点治疗宫癌的治疗策略.
- 这些结合了自我组装特性和在癌细胞中增强的亡疗效,表明了新型癌症治疗的潜力.
更多相关视频
10:23Author Spotlight: Optimization of Ultrashort Peptide Matrices for Colorectal Cancer Organoids
Published on: May 3, 2024
1.4K
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
8.0K
相关概念视频
Caspases
13.7K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
13.7K
Cancer Cell Migration through Invadopodia
3.2K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K
The Extrinsic Apoptotic Pathway
8.1K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.1K
Anaphase Promoting Complex
3.3K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K
The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K
